BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30314557)

  • 1. Moderate to severe vasomotor symptoms are risk factors for non-alcoholic fatty liver disease in postmenopausal women.
    Ryu KJ; Park H; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T
    Maturitas; 2018 Nov; 117():22-28. PubMed ID: 30314557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasomotor symptoms and osteoporosis in Korean postmenopausal women.
    Ryu KJ; Park HT; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T
    Maturitas; 2016 May; 87():27-32. PubMed ID: 27013285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasomotor symptoms and metabolic syndrome in Korean postmenopausal women.
    Ryu KJ; Park HT; Kwon DH; Yang KS; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T
    Menopause; 2015 Nov; 22(11):1239-45. PubMed ID: 25899005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasomotor Symptoms and Quality of Life Among Veteran and Non-Veteran Postmenopausal Women.
    Katon JG; Gray KE; Gerber MR; Harrington LB; Woods NF; Weitlauf JC; Bean-Mayberry B; Goldstein KM; Hunt JR; Katon WJ; Haskell SG; McCutcheon SJ; Gass ML; Gibson CJ; Zephyrin LC
    Gerontologist; 2016 Feb; 56 Suppl 1():S40-53. PubMed ID: 26220418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bothersome menopausal symptoms amongst postmenopausal Iranian women.
    Fooladi E; Bell RJ; Masoumi M; Azizi M; Atarod Z; Davis SR
    Climacteric; 2018 Dec; 21(6):586-593. PubMed ID: 30145921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomotor symptoms and carotid artery intima-media thickness among Korean midlife women.
    Ryu KJ; Park H; Park JS; Lee YW; Kim SY; Kim H; Lee YJ; Kim T
    Maturitas; 2022 May; 159():1-6. PubMed ID: 35337608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity.
    Whiteley J; Wagner JS; Bushmakin A; Kopenhafer L; Dibonaventura M; Racketa J
    Menopause; 2013 May; 20(5):518-24. PubMed ID: 23403500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasomotor symptom characteristics: are they risk factors for incident diabetes?
    Gray KE; Katon JG; LeBlanc ES; Woods NF; Bastian LA; Reiber GE; Weitlauf JC; Nelson KM; LaCroix AZ
    Menopause; 2018 May; 25(5):520-530. PubMed ID: 29206771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate-Severe Vasomotor Symptoms Are Associated with Moderate-Severe Depressive Symptoms.
    Worsley R; Bell RJ; Gartoulla P; Robinson PJ; Davis SR
    J Womens Health (Larchmt); 2017 Jul; 26(7):712-718. PubMed ID: 28263691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
    Zeleke BM; Bell RJ; Billah B; Davis SR
    Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey.
    Islam RM; Bell RJ; Billah B; Hossain MB; Davis SR
    Menopause; 2016 Jul; 23(7):731-9. PubMed ID: 26926325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum ferritin levels with non-alcoholic fatty liver disease in postmenopausal women.
    Kim HB; Lee HS; Lee YJ
    Climacteric; 2018 Oct; 21(5):509-514. PubMed ID: 30106314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal stages and non-alcoholic fatty liver disease in middle-aged women.
    Ryu S; Suh BS; Chang Y; Kwon MJ; Yun KE; Jung HS; Kim CW; Kim BK; Kim YJ; Choi Y; Ahn J; Cho YK; Kim KH; Ahn Y; Park HY; Chung EC; Shin H; Cho J
    Eur J Obstet Gynecol Reprod Biol; 2015 Jul; 190():65-70. PubMed ID: 25988514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women.
    Kim MK; Ahn CW; Nam JS; Kang S; Park JS; Kim KR
    Menopause; 2015 Dec; 22(12):1323-7. PubMed ID: 26154274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor Symptoms and Accelerated Epigenetic Aging in the Women's Health Initiative (WHI).
    Thurston RC; Carroll JE; Levine M; Chang Y; Crandall C; Manson JE; Pal L; Hou L; Shadyab AH; Horvath S
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1221-7. PubMed ID: 32080740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: A systematic review and meta-analysis.
    Armeni A; Anagnostis P; Armeni E; Mili N; Goulis D; Lambrinoudaki I
    Maturitas; 2023 May; 171():13-20. PubMed ID: 36907116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of menopausal vasomotor symptoms over the menopause transition.
    Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
    JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasomotor symptoms and the homeostatic model assessment of insulin-resistance in Korean postmenopausal women.
    Kwon DH; Lee JH; Ryu KJ; Park HT; Kim T
    Obstet Gynecol Sci; 2016 Jan; 59(1):45-9. PubMed ID: 26866035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.